| __timestamp | Grifols, S.A. | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 660772000 | 13774000 |
| Thursday, January 1, 2015 | 736435000 | 22479000 |
| Friday, January 1, 2016 | 775266000 | 27388000 |
| Sunday, January 1, 2017 | 860348000 | 35610000 |
| Monday, January 1, 2018 | 814775000 | 49007000 |
| Tuesday, January 1, 2019 | 942821000 | 61139000 |
| Wednesday, January 1, 2020 | 985616000 | 68836000 |
| Friday, January 1, 2021 | 1061508000 | 97592000 |
| Saturday, January 1, 2022 | 1190423000 | 106903000 |
| Sunday, January 1, 2023 | 1254234000 | 120998000 |
Infusing magic into the data realm
In the competitive landscape of the pharmaceutical and biotechnology sectors, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Grifols, S.A., a global leader in plasma-derived medicines, and Vericel Corporation, a pioneer in advanced cell therapies, offer a fascinating study in cost optimization from 2014 to 2023.
Grifols, S.A. has seen a steady increase in SG&A expenses, growing by approximately 90% over the decade. In contrast, Vericel Corporation, while starting with significantly lower expenses, has experienced a remarkable 780% increase. Despite this, Grifols' expenses remain over ten times higher than Vericel's, reflecting its larger scale of operations.
This data highlights the differing strategies and challenges faced by these companies in managing operational costs, providing valuable insights for investors and industry analysts alike.
Cost Management Insights: SG&A Expenses for Johnson & Johnson and Grifols, S.A.
BeiGene, Ltd. vs Vericel Corporation: SG&A Expense Trends
Neurocrine Biosciences, Inc. and Vericel Corporation: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Grifols, S.A. vs Ultragenyx Pharmaceutical Inc.
Grifols, S.A. vs Bausch Health Companies Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Grifols, S.A. and Arrowhead Pharmaceuticals, Inc.
Comparing SG&A Expenses: Grifols, S.A. vs Travere Therapeutics, Inc. Trends and Insights
Selling, General, and Administrative Costs: Cytokinetics, Incorporated vs Vericel Corporation
Rhythm Pharmaceuticals, Inc. and Vericel Corporation: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Veracyte, Inc. and Vericel Corporation
Comparing SG&A Expenses: Vericel Corporation vs Merus N.V. Trends and Insights
Cost Management Insights: SG&A Expenses for Vericel Corporation and Supernus Pharmaceuticals, Inc.